Track topics on Twitter Track topics that are important to you
CureDM, Inc., is a privately held, biopharmaceutical company focused on the discovery and development of new therapies that prevent, ameliorate, or reverse diseases of metabolism. CureDM is located in the Lankenau Institute for Medical Research (LIMR) at the Lankenau Hospital campus in Wynnewood, PA. CureDM has completed nearly all preclinical studies for its lead development compound, Pancreateâ¢ and expects to file an IND in early 2010 to conduct human clinical trials in both type 1 and type 2 diabetes. For more information visit www.limr.org and www.curedm.com.
Sanofi-aventis pact with CureDM to develop novel diabetes drug
CureDM, Inc., is a privately held, biopharmaceutical company focused on the discovery and development of new therapies that prevent, ameliorate, or reverse diseases of metabolism....
We have published hundreds of CureDM, Inc. news stories on BioPortfolio along with dozens of CureDM, Inc. Clinical Trials and PubMed Articles about CureDM, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CureDM, Inc. Companies in our database. You can also find out about relevant CureDM, Inc. Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...